The Quix Test: Identifying Vestibular Dysfunction in the “Dizzy Patient” (P7-4.004)

Abstract

<h3>Objective:</h3> Our objective was to validate the sensitivity and specificity of the Quix test in the identification of peripheral vestibular dysfunction in the “dizzy” patient and compare it to other conventional tests performed in the routine practice of the evaluation of “dizziness.” <h3>Background:</h3> The complaint of dizziness has ominous implications lending itself to accidental death and increased morbidity and mortality. The evaluation of a dizzy patient can be confounding due to its myriad of potential etiologies, many of which are present comorbidly. Acute peripheral vestibulopathy is a common cause of dizziness. Current conventional tests for vestibular dysfunction offer maximum sensitivity ranging from 50–75% (Cohen, 2019). We developed a modified version of the Quix test in an effort to increase sensitivity. <h3>Design/Methods:</h3> 158 patients were evaluated at a balance disorders clinic. Each patient underwent a comprehensive neurological examination and six assessments that detect vestibular dysfunction: a nystagmus test, a head impulse test, a Romberg test, a Quix test, a tandem stance/walk, and a sitting past-pointing test. Posturography, Dix-Hallpike maneuver, and videonystagmography were performed. Results were analyzed to determine the sensitivity of the vestibular tests in detecting dysfunction. <h3>Results:</h3> The association between the Quix test and vestibular dysfunction was assessed with a chi-square test. The model was statistically significant, χ2 = 4.3175 and p = 0.0377 &lt; .05 = α. The sensitivity was 85.7%, and the specificity was 33.3%. Although specificity was low, a number of patients were found to have benign positional vertigo on clinical examination by a balance therapist. Other conventional tests were not statistically significant predictor variables of vestibular abnormality. <h3>Conclusions:</h3> A positive Quix test helps identify vestibular dysfunction in the “dizzy patient.” It is cost-effective, time-efficient, and easily administered with minimal training. The Quix test is more sensitive than other conventional tests and can serve as a critical screening tool. <b>Disclosure:</b> Ms. Schusterman has nothing to disclose. Mr. Kuder has nothing to disclose. Miss Walker has nothing to disclose. Ms. Lee has nothing to disclose. Ms. Canut has nothing to disclose. Mr. Thompson has nothing to disclose. Charles Maitland has nothing to disclose. Dr. Gaillard has nothing to disclose. Dr. Solatikia has nothing to disclose.